Month: August 2021

Financial disasters and family tragedies left Kevin homeless and helpless. But with a determination to rebuild his life, and the generosity of strangers, he is on course towards a brighter future Nothing prepares you for becoming homeless. Years ago, growing up in Scotland, I would walk past rough sleepers and feel sorry for them, never
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. In a real-world setting, full vaccination against SARS-CoV-2 was more than 80% effective at reducing infection in people with inflammatory bowel disease (IBD) who were taking immunosuppressive medications. The study, which examined postvaccine infection rates in a Veterans Affairs cohort, further
0 Comments
STAMFORD, Conn., Aug. 03, 2021 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that the Company will be evaluating mirdametinib, an investigational MEK inhibitor, in a platform study sponsored by Memorial Sloan Kettering Cancer Center (MSK)
0 Comments
FDA Approves Nexviazyme (avalglucosidase alfa-ngpt) for Late-Onset Pompe Disease PARIS – August 6, 2021 – The U.S. Food and Drug Administration (FDA) has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset Pompe disease, a progressive and debilitating muscle disorder that impairs a person’s ability to move
0 Comments
August 6, 2021 Audience: Health Professional, Pharmacy  KVK Tech, Inc., is voluntarily recalling two lots of Atovaquone Oral Suspension, USP 750 mg/5mLto the consumer level. The recall is based on customer complaints of unusual grittiness in the product, which KVK has determined was most probably caused by prolonged exposure of these product lots to extremely
0 Comments
Idaho Gov. Brad Little on Friday called on the state’s residents to get vaccinated against Covid, citing concern about the delta variant and its potential to hinder economic progress. “We’re just urging everybody to get vaccinated,” Little said on CNBC’s “The Exchange.” Little said his biggest concern and “one of the most detrimental things” to
0 Comments
“It was complete chaos.” — Wajiha Jurdi Kheir, MD, an ophthalmologist at American University of Beirut Medical Center, describing her experience treating patients after last year’s blast at the nearby Port of Beirut in Lebanon. “We’ve had this flat ‘there’s no evidence boosters are indicated’ message. The messaging should be, ‘yes, we’re going to need
0 Comments
Please be advised that this video contains graphic footage of surgery. This video demonstrates a total parotidectomy performed by Dr. Eric J. Moore for cutaneous squamous cell carcinoma metastasized to the parotid gland. Series Editors: Andrew J. Goates, M.D.; Matthew L. Carlson, M.D.; David P. Larson, M.D. To learn more about the Department of Otorhinolaryngology
0 Comments
Aerobic exercise may help reduce blood pressure in patients whose hypertension responds poorly to medications, a new study suggests. A randomized controlled clinical trial showed that patients with resistant hypertension assigned to a moderate-intensity aerobic exercise training program had lower blood pressure (BP) compared with patients who received usual care. Dr Fernando Ribeiro “Resistant hypertension
0 Comments
A single cell can reveal much about the biological world through genomic sequencing. Scientists can compare a single, isolated cell to other samples, analyzing the differences and similarities to better understand how the organisms originated and evolved -; or even to discover entirely new species. However, despite the rapid development of single-cell sequencing technologies, sample
0 Comments
WILMINGTON, Del.–(BUSINESS WIRE) July 23, 2021–AstraZeneca’s Bydureon BCise (exenatide extended-release), once-weekly injectable suspension has been approved in the US for the treatment of type 2 diabetes (T2D); to improve glycemic control in pediatric patients (10 to 17 years) as an adjunct to diet and exercise. The approval by the US Food and Drug Administration (FDA)
0 Comments
Young cancer patients face unique challenges. That’s why the UC Davis Comprehensive Cancer Center started an Adolescent and Young Adult (AYA) Oncology Program in 2020. The COVID-19 pandemic, which was unfolding just as the AYA program launched, only strengthened the resolve of cancer center staff members to provide support quickly to cancer patients in their
0 Comments
A head-to-head randomized comparison of milrinone and dobutamine — the most used inotropes in cardiogenic shock therapy in North America — failed to find a significant advantage for one agent over the other. Patients treated with milrinone and dobutamine had similar rates of the primary composite outcome (49% vs 54%; relative risk [RR], 0.90; 95%
0 Comments